Drugs / COVID-19 Vaccine,Inactivated
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | COVID-19 Vaccine (inactivated, adjuvanted) Valneva | — | 2023-10-12 | europa.eu ↗ |
| Approved | EU (EMA) | COVID-19 Vaccine (inactivated, adjuvanted) Valneva | — | 2022-06-24 | europa.eu ↗ |
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05156632 | Feb 2023 | COVID-19 | Sinovac Research and Development Co., Ltd. | Withdrawn | No outcome recorded |
| Phase 3 | NCT05137418 | Nov 2021 → Jan 2023 | COVID-19 | Sinovac Research and Development Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-19 Vaccine,Inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05137418 ↗ |
| Modality | Vaccine | “COVID-19 Vaccine,Inactivated” NCT05137418 ↗ |